| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 4.251.790 $ | 97,42 | 310.266 | |||||||
| Novo Nordisk A/S | Novo Nordisk A/S | EC | 670100205 | Long | Börsenkurs (Stufe 1) | 425.755 $ | 9,76 | 8.881 | |
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 404.208 $ | 9,26 | 337 | |
| Scholar Rock Holding Corp | Scholar Rock Holding Corp | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 249.205 $ | 5,71 | 4.531 | |
| Hims & Hers Health Inc | Hims & Hers Health Inc | EC | 433000106 | Long | Börsenkurs (Stufe 1) | 243.141 $ | 5,57 | 7.013 | |
| Viking Therapeutics Inc | Viking Therapeutics Inc | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 239.599 $ | 5,49 | 6.142 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 226.728 $ | 5,20 | 901 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 221.870 $ | 5,08 | 2.722 | |
| Innovent Biologics Inc | Innovent Biologics Inc | EC | KYG4818G1010 | Long | Börsenkurs (Stufe 1) | 218.234 $ | 5,00 | 21.500 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 199.890 $ | 4,58 | 552 | |
| Chugai Pharmaceutical Co Ltd | Chugai Pharmaceutical Co Ltd | EC | JP3519400000 | Long | Börsenkurs (Stufe 1) | 199.331 $ | 4,57 | 4.300 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 199.175 $ | 4,56 | 1.550 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 198.911 $ | 4,56 | 1.049 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Börsenkurs (Stufe 1) | 197.209 $ | 4,52 | 478 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 195.792 $ | 4,49 | 314 | |
| CSPC Pharmaceutical Group Ltd | CSPC Pharmaceutical Group Ltd | EC | HK1093012172 | Long | Börsenkurs (Stufe 1) | 195.536 $ | 4,48 | 220.000 | |
| Pfizer Inc | Pfizer Inc | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 191.605 $ | 4,39 | 7.957 | |
| Zealand Pharma A/S | Zealand Pharma A/S | EC | DK0060257814 | Long | Börsenkurs (Stufe 1) | 152.109 $ | 3,49 | 3.434 | |
| Kailera Therapeutics Inc | Kailera Therapeutics Inc | EC | 482931102 | Long | Börsenkurs (Stufe 1) | 107.154 $ | 2,46 | 4.864 | |
| Jiangsu Hengrui Pharmaceutical | Jiangsu Hengrui Pharmaceuticals Co Ltd | EC | CNE100006XS6 | Long | Börsenkurs (Stufe 1) | 98.850 $ | 2,26 | 13.400 | |
| Hanmi Pharm Co Ltd | Hanmi Pharm Co Ltd | EC | KR7128940004 | Long | Börsenkurs (Stufe 1) | 87.490 $ | 2,00 | 341 | |
| 4.251.790 $ | 97,42 | 310.266 |